| T5544 |
2-Furoic acid
|
88-14-2
|
98%
|
|
|
2-Furoic acid (Furan-2-carboxylic acid) 2-Furoic acid can reduce serum cholesterol and triglyceride levels and has anti-lipidemic effects.
|
| T7424 |
NDI-091143
|
2375840-87-0
|
98%
|
|
|
NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay),indirectly disrupting citrate binding vi...
|
| T2337 |
BMS-303141
|
943962-47-8
|
98%
|
|
|
BMS-303141 is a potent ATP-citrate lyase (ACL) inhibitor (IC50: 0.13 uM, human recombinant ACL).
|
| T11590 |
(-)-Hydroxycitric acid
|
27750-10-3
|
|
|
|
(-)-Hydroxycitric acid (Garcinia acid) (Garcinia acid) is the principal acid of fruit rinds of Garcinia cambogia. It is a potent and competitive inhibitor of ATP...
|
| T11589 |
Hydroxycitric acid tripotassium hydrate
|
6100-05-6
|
95%
|
|
|
Hydroxycitric acid tripotassium hydrate (Potassium citrate monohydrate) effectively inhibits stones formation and also inhibits HIF, and has antioxidation, anti-...
|
| T22967 |
MEDICA16
|
87272-20-6
|
99.13%
|
|
|
MEDICA16 is a selective agonist for GPR40 as well as a partial agonist for GPR120. MEDICA16, an ATP-citrate lyase inhibitor, significantly reduces intracellular ...
|
| T16861 |
SB 204990
|
154566-12-8
|
99.6%
|
|
|
SB 204990 is an effective and specific ATP citrate lyase enzyme inhibitor.
|
| T3625 |
Bempedoic acid
|
738606-46-7
|
99.84%
|
|
|
Bempedoic acid (ETC1002) is an orally available, once-daily LDL-C lowering small molecule designed to lower elevated levels of LDL-C and to avoid side effects as...
|
| T12045 |
(-)-Hydroxycitric acid lactone
|
27750-13-6
|
99.91%
|
|
|
(-)-Hydroxycitric acid lactone (Garcinia lactone) is an anti-obesity agent.(-)-Hydroxycitric acid lactone was a potent inhibitor of ATP citrate lyase, which cata...
|
| T79936 |
Forrestiacids K
|
2920898-65-1
|
98%
|
|
|
Forrestiacid K, a terpenoid derived from Pseudotsuga forrestii, functions as an inhibitor of ATP-citrate lyase (ACL) [1].
|
| T79935 |
Forrestiacids J
|
2920898-66-2
|
98%
|
|
|
Forrestiacid J is an inhibitor of ATP-citrate lyase (ACL), exhibiting an IC50 value of 2.6 μM [1].
|
